Regeneron Pharmaceuticals has recently acquired the Avon Innovation Center, a 235,000-square-foot research and development property located in Suffern, NY. The purchase price for this transaction was not disclosed.
The seller was represented by a team from Cushman & Wakefield led by Larry Carroll, Shawn Straka, David Bernhaut, Frank DiTommaso and Seth Zuidema. Michael Katz of Actio Corporate Advisors also assisted with the sale process. On the other hand,the buyer Regeneron Pharmaceuticals was represented by Dan Loughlin and Matt Loughlin of JLL.
“We are delighted to have successfully sold Avon’s iconic facility in Suffern,” stated Bernhaut confidently.”This acquisition marks a significant user transaction within the market that presents promising economic growth opportunities for the surrounding region.We were honored to collaborate with Actio Corporate Advisors and provide support to Avon’s global real estate team throughout this entire process.”
The article titled “Regeneron Pharmaceuticals Buys Avon R&D Facility in Suffern” originally appeared on Connect CRE website.
